Brittany Ratliff Garrison, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 311 W Phifer St, Marshville, NC 28103 Phone: 704-624-6643 Fax: 704-624-2022 |
Sarah Bradley Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 820 Old Pageland Marshville, Marshville, NC 28103 Phone: 704-989-3834 |
Katlyn Sigmon Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 311 W Phifer St, 608, Marshville, NC 28103 Phone: 704-624-6643 |
News Archive
A new investigation published in JAMA Psychiatry finds that while insurance coverage for depression has increased, treatment rates are lower than expected, indicating that non-financial barriers to patient care still remain.
The American Society of Clinical Oncology (ASCO) has once again recognized Erbitux® (cetuximab) as one of the major clinical cancer advances of 2009. This year Erbitux was selected by ASCO for providing the first significant increase in survival for 30 years in the treatment of patients with 1st-line recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN).
Pulmonary rehabilitation (PR) treatment could be a valuable addition to comprehensive therapy in patients with obstructive sleep apnea (OSA) syndrome, according to a new study. The study was presented at the 2015 American Thoracic Society International Conference.
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have shown that a well-known cancer-causing gene implicated in a number of malignancies plays a far more critical role in non-small cell lung cancer, the most common form of the disease, than previously thought.
Bartonella bacteria are increasingly recognized as an emerging infectious disease threat. A new study by North Carolina State University researchers has found additional instances of Bartonella infection in humans who exhibited neuropsychiatric symptoms, a subset of whom also had skin lesions.
› Verified 2 days ago